Total Payments
$108,383
2024 Payments
$44,508
Companies
44
Transactions
649
Medicare Patients
5,507
Medicare Billing
$535,888
Payment Breakdown by Category
Other$60,228 (55.6%)
Consulting$21,858 (20.2%)
Food & Beverage$14,429 (13.3%)
Travel$11,754 (10.8%)
Education$116.12 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $58,723 | 31 | 54.2% |
| Consulting Fee | $21,858 | 9 | 20.2% |
| Food and Beverage | $14,429 | 560 | 13.3% |
| Travel and Lodging | $11,754 | 46 | 10.8% |
| Honoraria | $1,505 | 1 | 1.4% |
| Education | $116.12 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | $42,809 | 70 | $0 (2024) |
| PFIZER INC. | $32,109 | 86 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $10,561 | 12 | $0 (2023) |
| Eli Lilly Export S.A. Puerto Rico Branch | $5,673 | 4 | $0 (2019) |
| Celgene Corporation | $4,645 | 40 | $0 (2024) |
| ABBVIE INC. | $2,598 | 130 | $0 (2024) |
| Eli Lilly and Company | $1,738 | 19 | $0 (2020) |
| RedHill Biopharma Inc. | $1,505 | 2 | $0 (2020) |
| IRONWOOD PHARMACEUTICALS, INC | $1,024 | 10 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $864.72 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44,508 | 163 | Phathom Pharmaceuticals, Inc. ($42,809) |
| 2023 | $6,312 | 92 | E.R. Squibb & Sons, L.L.C. ($4,629) |
| 2022 | $8,806 | 127 | E.R. Squibb & Sons, L.L.C. ($5,932) |
| 2021 | $533.84 | 28 | Janssen Biotech, Inc. ($154.75) |
| 2020 | $6,979 | 20 | PFIZER INC. ($2,345) |
| 2019 | $33,112 | 123 | PFIZER INC. ($26,229) |
| 2018 | $4,945 | 76 | Celgene Corporation ($1,874) |
| 2017 | $3,186 | 20 | PFIZER INC. ($2,877) |
All Payment Transactions
649 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $85.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: GI | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Honoraria | Cash or cash equivalent | $1,505.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $104.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: GI | ||||||
| 11/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,019 | 1,104 | $403,163 | $106,857 |
| 2022 | 17 | 1,420 | 1,721 | $484,481 | $128,616 |
| 2021 | 17 | 1,536 | 1,860 | $524,306 | $153,721 |
| 2020 | 18 | 1,532 | 1,987 | $462,718 | $146,693 |
Total Patients
5,507
Total Services
6,672
Medicare Billing
$535,888
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 138 | 139 | $118,150 | $27,459 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 232 | 296 | $51,800 | $18,510 | 35.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 183 | 183 | $32,025 | $13,273 | 41.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 52 | 52 | $31,512 | $8,965 | 28.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 119 | 121 | $56,870 | $8,704 | 15.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 45 | 45 | $27,270 | $7,927 | 29.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 76 | $15,200 | $7,215 | 47.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 43 | 43 | $30,616 | $3,816 | 12.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $7,000 | $3,541 | 50.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $9,696 | $2,077 | 21.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $8,358 | $1,770 | 21.2% |
| 43450 | Dilation of esophagus | Facility | 2023 | 43 | 43 | $10,320 | $1,314 | 12.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 13 | $2,600 | $1,203 | 46.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 17 | $1,581 | $1,035 | 65.5% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 11 | 11 | $165.00 | $47.19 | 28.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 139 | 139 | $118,150 | $25,206 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 280 | 390 | $68,250 | $22,745 | 33.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 219 | 219 | $38,325 | $14,011 | 36.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 129 | 129 | $60,630 | $8,817 | 14.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 48 | 48 | $29,088 | $8,674 | 29.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 43 | 43 | $26,058 | $7,810 | 30.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 149 | 305 | $34,900 | $7,284 | 20.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 69 | 69 | $14,000 | $6,537 | 46.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 58 | $11,650 | $5,321 | 45.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 74 | 95 | $8,835 | $4,748 | 53.7% |
About Dr. Keith Friedenberg, M.D
Dr. Keith Friedenberg, M.D is a Gastroenterology healthcare provider based in Mentor, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104928043.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keith Friedenberg, M.D has received a total of $108,383 in payments from pharmaceutical and medical device companies, with $44,508 received in 2024. These payments were reported across 649 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($58,723).
As a Medicare-enrolled provider, Friedenberg has provided services to 5,507 Medicare beneficiaries, totaling 6,672 services with total Medicare billing of $535,888. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Mentor, OH
- Active Since 09/01/2006
- Last Updated 03/03/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1104928043
Products in Payments
- VOQUEZNA (Drug) $42,809
- XELJANZ (Drug) $30,146
- ZEPOSIA (Drug) $2,770
- Ozanimod (Drug) $1,874
- Talicia (Drug) $1,500
- STELARA (Biological) $784.92
- LINZESS (Drug) $663.79
- RINVOQ (Biological) $617.48
- Amitiza (Drug) $550.00
- DUPIXENT (Biological) $374.63
- Humira (Biological) $346.72
- VIBERZI (Drug) $293.41
- DIFICID (Drug) $256.05
- XIFAXAN (Drug) $235.97
- SKYRIZI (Biological) $220.27
- IBSRELA (Drug) $200.16
- ENTYVIO (Biological) $192.18
- CREON (Drug) $169.87
- VOWST (Biological) $164.54
- ZENPEP (Drug) $155.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Mentor
Keyur Parikh, M.d, M.D
Gastroenterology — Payments: $43,538
Gastroenterology $43,538
Dr. Sayed Khatami, M.d, M.D
Gastroenterology — Payments: $34,306
Gastroenterology $34,306
Rami Abbass, M.d, M.D
Gastroenterology — Payments: $11,913
Gastroenterology $11,913
Bridget Gallagher, Md, MD
Gastroenterology — Payments: $2,849
Gastroenterology $2,849
Emily Carey, Do, DO
Gastroenterology — Payments: $901.59
Gastroenterology $901.59